PL2448606T3 - Materiał biologiczny odpowiedni do terapii choroby zwyrodnieniowej stawów, uszkodzenia więzadła i leczenia schorzeń stawów - Google Patents

Materiał biologiczny odpowiedni do terapii choroby zwyrodnieniowej stawów, uszkodzenia więzadła i leczenia schorzeń stawów

Info

Publication number
PL2448606T3
PL2448606T3 PL10729841T PL10729841T PL2448606T3 PL 2448606 T3 PL2448606 T3 PL 2448606T3 PL 10729841 T PL10729841 T PL 10729841T PL 10729841 T PL10729841 T PL 10729841T PL 2448606 T3 PL2448606 T3 PL 2448606T3
Authority
PL
Poland
Prior art keywords
osteoarthrosis
therapy
treatment
biological material
material suitable
Prior art date
Application number
PL10729841T
Other languages
English (en)
Inventor
Lanfranco Callegaro
Anna Maria Zanellato
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of PL2448606T3 publication Critical patent/PL2448606T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10729841T 2009-07-02 2010-06-29 Materiał biologiczny odpowiedni do terapii choroby zwyrodnieniowej stawów, uszkodzenia więzadła i leczenia schorzeń stawów PL2448606T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2009A001171A IT1394570B1 (it) 2009-07-02 2009-07-02 Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
EP10729841.6A EP2448606B1 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders
PCT/EP2010/059183 WO2011000820A2 (en) 2009-07-02 2010-06-29 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders

Publications (1)

Publication Number Publication Date
PL2448606T3 true PL2448606T3 (pl) 2013-10-31

Family

ID=41716303

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10729841T PL2448606T3 (pl) 2009-07-02 2010-06-29 Materiał biologiczny odpowiedni do terapii choroby zwyrodnieniowej stawów, uszkodzenia więzadła i leczenia schorzeń stawów

Country Status (15)

Country Link
US (1) US8771672B2 (pl)
EP (1) EP2448606B1 (pl)
CN (1) CN102470190B (pl)
CA (1) CA2763945C (pl)
DK (1) DK2448606T3 (pl)
ES (1) ES2421300T3 (pl)
HR (1) HRP20130509T1 (pl)
IT (1) IT1394570B1 (pl)
MY (1) MY155301A (pl)
PL (1) PL2448606T3 (pl)
PT (1) PT2448606E (pl)
RU (1) RU2529803C2 (pl)
SG (1) SG176110A1 (pl)
SI (1) SI2448606T1 (pl)
WO (1) WO2011000820A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20130110A1 (it) * 2013-04-24 2014-10-25 Fidia Farmaceutici Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
CN103340904B (zh) * 2013-07-10 2016-03-23 西比曼生物科技（香港）有限公司 治疗骨关节炎的组合物
RU2565413C1 (ru) * 2014-04-22 2015-10-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный аграрный университет имени Н.И. Вавилова" Способ лечения остеоартроза у животных
TWI566774B (zh) * 2014-10-06 2017-01-21 佛教慈濟醫療財團法人花蓮慈濟醫院 治療關節疾病的組成物及其方法
CN105106238A (zh) * 2015-08-10 2015-12-02 山东省药学科学院 一种用于治疗骨关节炎和软骨缺损的细胞治疗组合物
US9861410B2 (en) 2016-05-06 2018-01-09 Medos International Sarl Methods, devices, and systems for blood flow
RU2624230C1 (ru) * 2016-07-13 2017-07-03 Федеральное государственное бюджетное учреждение "Приволжский федеральный медицинский исследовательский центр" Министерства здравоохранения Российской Федерации Способ лечения больных при острой стадии диабетической нейростеоартропатии по типу "стопа Шарко"
CN107550935A (zh) * 2017-09-11 2018-01-09 上海亚睿生物科技有限公司 一种治疗关节疾病的生物凝胶剂及其应用
CN108653329A (zh) * 2018-05-28 2018-10-16 广东唯泰生物科技有限公司 一种用于治疗骨关节炎的药物及其制备方法
RU2708376C1 (ru) * 2018-12-12 2019-12-06 Александр Сергеевич Тепляшин Биомедицинская композиция для лечения дегенеративных заболеваний суставов на основе региональных стволовых клеток взрослого организма
CN110237095A (zh) * 2019-05-28 2019-09-17 武汉汉密顿生物科技股份有限公司 用于治疗骨性关节炎软骨缺损的干细胞注射液及其制备和应用
IT201900009933A1 (it) 2019-06-24 2020-12-24 Fidia Farm Spa Composizioni farmaceutiche comprendenti derivati ammidici dell'acido ialuronico per uso nel trattamento di traumi ossei, in particolare in pazienti con problemi di osteopenia o osteoporosi

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1282207B1 (it) 1995-11-20 1998-03-16 Fidia Advanced Biopolymers Srl Sistemi di coltura di cellule staminali di midollo osseo umano in matrici tridimensionali costituiti da esteri dell'acido ialuronico
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
RU2306335C2 (ru) * 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
ITAL990010U1 (it) 1999-12-14 2001-06-14 Maria Cristina Sacchi Nuova metodica di laboratorio per preparare gel e membrane piastriniche ottenute dal concentrato piastrinico.
DE60143517D1 (de) * 2000-04-25 2011-01-05 Osiris Therapeutics Inc Wiederherstellung der gelenken mit mesenchymalen stammzellen
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CN1859918B (zh) * 2003-10-09 2010-07-07 罗伯特·约翰·佩特雷拉 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用
ITPD20050056A1 (it) * 2005-03-02 2006-09-03 Fidia Farmaceutici Derivati ammidici del'acido ialuronico in osteoartrosi
CA2647549A1 (en) * 2006-03-31 2007-10-11 Csir Bulking of soft tissue
US20090274627A1 (en) * 2006-04-19 2009-11-05 National University Corporation Nagoya University Composition for Regeneration of Periodontal Soft Tissue and Method for Producing the Same
CN100594029C (zh) * 2006-07-24 2010-03-17 凌沛学 一种关节腔内注射用药物组合物
US8034014B2 (en) * 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
ES2333498B1 (es) * 2007-08-02 2011-01-10 Biotechnology Institute, I Mas D, S.L. Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto.

Also Published As

Publication number Publication date
ES2421300T3 (es) 2013-08-30
WO2011000820A3 (en) 2011-04-07
IT1394570B1 (it) 2012-07-05
SG176110A1 (en) 2011-12-29
RU2529803C2 (ru) 2014-09-27
SI2448606T1 (sl) 2013-09-30
ITMI20091171A1 (it) 2011-01-03
HK1165336A1 (en) 2012-10-05
CA2763945A1 (en) 2011-01-06
US20120114609A1 (en) 2012-05-10
CN102470190A (zh) 2012-05-23
CN102470190B (zh) 2015-09-02
CA2763945C (en) 2017-11-14
DK2448606T3 (da) 2013-08-05
MY155301A (en) 2015-09-30
HRP20130509T1 (hr) 2013-08-31
WO2011000820A2 (en) 2011-01-06
EP2448606A2 (en) 2012-05-09
EP2448606B1 (en) 2013-05-15
PT2448606E (pt) 2013-07-12
US8771672B2 (en) 2014-07-08
RU2012103465A (ru) 2013-08-10

Similar Documents

Publication Publication Date Title
SI2448606T1 (sl) Biološki matrial primeren za zdravljenje osteoartroze, poškodb ligamentov in za zdravljenje sklepnih nepravilnosti
GB0700560D0 (en) Device and method for the treatment of diseased tissue such as tumours
IL210856A0 (en) Combination therapy for the treatment of diabetes and related conditions
EP2166837A4 (en) DRUG COMBINATION USEFUL FOR THE TREATMENT OF SKIN DISORDERS
ZA200907137B (en) Novel N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
ZA200906210B (en) 3-Imidazolyl-Indoles for the treatment of proliferative diseases
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
ZA201001194B (en) Heterocyclic amides useful for the treatment of cancer and psoriasis
SI2391650T1 (sl) Postopki za zdravljenje protina
ZA201105284B (en) Visfatin therapeutic agents for the treatment of acne and other conditions
ZA201001262B (en) Interval therapy for the treatment of tinnitus
IL218143A0 (en) Substituted heterocyclic derivatives for the treatment of pain and epilepsy
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
IL193669A0 (en) Apparatus for the treatment of bruxism
IL225755A0 (en) Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL213703A (en) Compounds for the treatment of pain and other diseases
EP2318011A4 (en) METHODS AND MATERIALS FOR TREATING ACNE
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
PL1982178T3 (pl) Sposoby leczenia zaburzeń afektywnych
IL206435A0 (en) Therapeutic regimens for the treatment of immunoinflammatory disorders
IL207668A0 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
EP2203174A4 (en) THERAPEUTIC REGIMES FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders